Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial

OBJECTIVES: This post hoc analysis of TIOtropium Safety and Performance In Respimat (TIOSPIR) evaluated safety and exacerbation efficacy in patients with stable (≥2 months) use of tiotropium HandiHaler 18 µg (HH18) prior to study entry, to evaluate whether there was a difference in risk for patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahl, Ronald, Calverley, Peter M A, Anzueto, Antonio, Metzdorf, Norbert, Fowler, Andy, Mueller, Achim, Wise, Robert, Dusser, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710815/
https://www.ncbi.nlm.nih.gov/pubmed/26715479
http://dx.doi.org/10.1136/bmjopen-2015-009015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710815/
https://www.ncbi.nlm.nih.gov/pubmed/26715479
http://dx.doi.org/10.1136/bmjopen-2015-009015

Ejemplares similares